Molecular Cytogenetics Market Projection, Technological Innovation And Emerging Trends 2030 The molecular cytogenetics is a study of genetic disorders that utilizes advanced technologies which combine molecular and cytogenetic techniques. FISH also known as Fluorescence in situ hybridization, is considered as the only remaining molecular cytogenetics approach. FISH is utilized in numerous ways in research and diagnostics. It is simple and a well-established approach in numerous commercially available and applicable probe sets. Types of Target-Samples in FISH Considering the FISH experiments, the samples need to contain intact, for non-degraded high molecular weight target-DNA. All such tissues that fulfil the prerequisite can be used in FISH. The multicellular organisms, extracted nuclei, metaphase chromosomes, tissue sections, or pure DNA can be utilized as target-DNA. Even bacteria can be used for this. The native cells, tissue sections, metaphase chromosomes, extracted nuclei, or pure DNA can be utilized as target-DNA in multicellular organisms. Browse detailed report - https://www.psmarketresearch.com/market-analysis/molecular-cytogenetics-market Chromosome Orientation-FISH Chromosome orientation-FISH facilitates selectively marking of specifically one of the two homologous chromosome DNA strands by incorporating 5-bromodeoxyuridine in one DNA strand and destroying it through EXOIII enzyme treatment and UV-light. The major players operating in the industry are Danaher Corporation, Abbott Laboratories, Quest Diagnostics Inc., NeoGenomics Inc., Bio-Rad Laboratories, F.Hoffmann La-Roche AG, and NeoGenomics Inc. Therefore, the rising usage of the molecular cytogenetics in the routine diagnostics propels the industry.